Association of Serum Interleukin-17 and Interleukin-23 Levels with Disease Activity, Function, Mobility, Enthesitis Index in Patients with Ankylosing Spondylitis
Aktuelle Rheumatologie · 01.04.2023 · 48 (02) · 131-136
DOI: 10.1055/a-1836-9905 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aktuelle Rheumatologie, erschienen am 01.04.2023. Verfasst von Münevver Serdaroğlu Beyazal und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Themen: Mobilisation
Abstract (Originalsprache)
Aim
More and more studies have demonstrated that the interleukin (IL)-23/IL-17 axis is highly associated with immune dysfunction and activated autoimmune inflammation. The purposes of this study were to determine the serum levels of IL-17 and IL-23 in ankylosing spondylitis (AS) patients compared with healthy controls and evaluate these cytokine levels based on disease-related characteristics. Material and Methods: Eighty-six consecutive AS patients and 70 sex and age-matched healthy controls were included in the study. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Ankylosing Spondylitis Disease Activity Score (ASDAS)-erythrocyte sedimentation rate (ESR), ASDAS-C reactive protein, the Bath Ankylosing Spondylitis Functional Index (BASFI), the Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index, the Bath Ankylosing Spondylitis Metrology Index (BASMI), the Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL) and Achilles pain VAS scores were recorded. Serum IL-17 and IL-23 levels were examined by enzyme-linked immunosorbent assay.
Results
The serum levels of IL-17, IL-23 and CRP as well as ESR values were significantly increased in AS patients compared with controls (1.94 vs. 0.28 pg/mL p ˂ 0.001; 82.9 vs. 44.3 pg/mL p ˂ 0.001; 0.48 vs. 0.30 mg/dL, p=0.001; 12±13.9 vs. 8±6.8 mm/h, p=0.003, respectively). In AS patients, serum IL-17 levels were significantly correlated with the ASDAS-ESR and ASDAS-CRP (r=0.244, p=0.024; r=0.258, p=0.017), but not with ESR, CRP, BASDAI, function, mobility, quality of life, enthesitis index or Achilles pain scores (all p>0.05). Serum IL-23 levels demonstrated a significant correlation with Achilles pain VAS, but not with other disease-related parameters (all p>0.05).
Conclusions
AS patients had increased serum IL-17 and IL-23 levels compared with healthy controls, and serum IL-17 levels were associated with disease activity. Our study results support the hypothesis that the IL17/23 pathway plays an important role in the pathogenesis of AS.
Zitieren
APA
Beyazal, M. S., Tayfun, A., Devrimsel, G., Yıldırım, M., & Arpa, M. (2023). Association of Serum Interleukin-17 and Interleukin-23 Levels with Disease Activity, Function, Mobility, Enthesitis Index in Patients with Ankylosing Spondylitis. Aktuelle Rheumatologie, 48(02), 131-136. https://doi.org/10.1055/a-1836-9905
Vancouver
Beyazal MS, Tayfun A, Devrimsel G, Yıldırım M, Arpa M. Association of Serum Interleukin-17 and Interleukin-23 Levels with Disease Activity, Function, Mobility, Enthesitis Index in Patients with Ankylosing Spondylitis. Aktuelle Rheumatologie. 2023;48(02):131-136. doi:10.1055/a-1836-9905
BibTeX
@article{Beyazal2023,
author = {Beyazal, Münevver Serdaroğlu and Tayfun, Aliekber and Devrimsel, Gul and Yıldırım, Murat and Arpa, Medeni},
title = {Association of Serum Interleukin-17 and Interleukin-23 Levels with Disease Activity, Function, Mobility, Enthesitis Index in Patients with Ankylosing Spondylitis},
journal = {Aktuelle Rheumatologie},
year = {2023},
volume = {48},
number = {02},
pages = {131--136},
doi = {10.1055/a-1836-9905}
}
EUVIMED